Stanford University
Showing 5,551-5,600 of 36,197 Results
-
William Choi, D.M.D.
Clinical Associate Professor, Surgery - Plastic & Reconstructive Surgery
BioClinical focus in Hospital Dentistry serving as needed for hospital inpatients, dental oncology, adults with disability and emergency room patients who need dental consultation or treatment.
-
Yejin Choi
Dieter Schwarz Foundation HAI Professor and Senior Fellow at the Stanford Institute for Human-Centered Artificial Intelligence
BioYejin Choi is the Dieter Schwarz Foundation Professor and Senior Fellow at the Department of Computer Science at Stanford University and the Stanford Institute for Human-Centered Artificial Intelligence (HAI) respectively. Choi is MacArthur Fellow (class of 2022), AI2050 Senior Fellow (class of 2024), and named among Time100 Most Influential People in AI in 2023. In addition, Choi is a co-recipient of 2 Test-of-Time awards and 8 Best and Outstanding Paper Awards at top AI conferences including ACL, ICML, NeurIPS, ICCV, CVPR, and AAAI, the Borg Early Career Award (BECA) in 2018, the inaugural Alexa Prize Challenge in 2017, and IEEE AI’s 10 to Watch in 2016. Choi was a main stage speaker at TED 2023, and a keynote speaker for a dozen conferences across several AI disciplines including ACL, CVPR, ICLR, MLSys, VLDB, WebConf, and AAAI. Her current research interests include fundamental limits and capabilities of large language models, alternative training recipes for language models, symbolic methods for neural networks, reasoning and knowledge discovery, moral norms and values, pluralistic alignment, and AI safety.
-
Helene Chokron Garneau
Sr Research Scholar, Psych/Public Mental Health & Population Sciences
Current Role at StanfordSenior Research Scientist
Co-Director, Center for Dissemination and Implementation At Stanford (C-DIAS) -
Matthieu Chollet
Staff Scientist, SLAC National Accelerator Laboratory
Current Role at StanfordX-ray Correlation Spectroscopy (XCS) instrument lead
LCLS Material Science Department -
Jinie Chon
Fws-Stanford Student Employee, Public Policy
Undergraduate, Public PolicyBioUndergraduate pursuing Public Policy at Stanford.
For more information, please visit: linkedin.com/in/jiniechon -
Curtis R. Chong, MD, PhD, MPhil, FACP
Clinical Assistant Professor, Medicine - Oncology
BioDr. Chong was recruited to Stanford from the Memorial Sloan Kettering (MSK) Cancer Center, where he led MSK's launch of the early drug development and immunotherapy clinical trials program in New Jersey. At MSK, Dr. Chong was a member of the gastrointestinal oncology service and was one of two MSK physicians in New Jersey who specialized in treating melanoma. Prior to joining MSK, Dr. Chong was a member of the thoracic oncology service at the Dana-Farber Cancer Institute and an attending physician at the Massachusetts General Hospital and Brigham and Women's Hospital, all ailiates of Harvard Medical School.
Dr. Chong completed his categorical residency in internal medicine at the Massachusetts General Hospital/Harvard Medical School, his oncology fellowship at the Dana-Farber Cancer Institute, and is board-certified in internal medicine and medical oncology. He has received research support from the American Society of Clinical Oncology (Young Investigator Award), Uniting Against Lung Cancer, and the American Cancer Society. Dr. Chong has been published in the New England Journal of Medicine, Nature, Nature Medicine, Nature Chemical Biology, JAMA Oncology, and his research on drug discovery has been featured in the New York Times and Popular Science.
Born and raised in Honolulu where he attended public schools, Dr. Chong sang in the Honolulu Boy Choir, and was the 1993 Honolulu Star Bulletin Newspaper Boy of the Year. He received his A.B. in biochemical sciences from Harvard University magna cum laude followed by an M.Phil. in Chemistry with Sir Alan Fersht at the University of Cambridge (Emmanuel College). He then received his MD and PhD in pharmacology from The Johns Hopkins University School of Medicine.
An intrepid traveler and avid long-distance runner, Dr. Chong has visited 54 countries and completed 126 marathons in all 50 states, 18 countries, and 6 on continents. -
HyeRan Choo
Clinical Associate Professor, Surgery - Plastic & Reconstructive Surgery
BioDr. HyeRan Choo is a Clinical Associate Professor and Section Chief of Craniofacial Airway Orthodontics in the Department of Surgery, Division of Plastic and Reconstructive Surgery at Stanford University School of Medicine. She also serves as the Director of the Stanford Orthodontic Airway Plate Treatment Program for Pierre Robin Sequence (SOAP for PRS) at Lucile Packard Children’s Hospital Stanford and is a faculty fellow at the Stanford Mussallem Center for Biodesign.
Dr. Choo earned her dental degrees from Seoul National University (combined Undergraduate and Graduate Dental Surgery program) and The University of Pennsylvania (Dental Medicine program). She completed her Post-graduate Orthodontic Residency and Master of Science degree at The University of Alabama in Birmingham. After a Craniofacial Fellowship at the National Institutes of Health / National Institute of Dental and Craniofacial Research, Dr. Choo served as Director of Craniofacial Orthodontics at The Children’s Hospital of Philadelphia / The University of Pennsylvania.
In 2012, Dr. Choo relocated to the San Francisco Bay Area, where she became a craniofacial orthodontic provider for Kaiser Permanente Medical Centers in Oakland and Santa Clara. She joined the Stanford University faculty in 2016 as a part-time craniofacial orthodontist and clinical instructor and transitioned to a full-time position in 2019 as a craniofacial airway orthodontist and clinical assistant professor.
Her clinical expertise includes surgical and non-surgical craniofacial and airway orthodontic treatments for neonates, infants, and children with craniofacial dysmorphism and/or orofacial dysfunctions. Dr. Choo's treatment philosophy centers on providing minimally invasive yet highly effective treatments, grounded in a deep understanding of craniofacial growth and function. Her SOAP for PRS program is the first in the nation to non-surgically treat neonates with PRS using OAP, which she fabricates based on her innovative method of analyzing maxillomandibular computed tomography. -
Monica Seungah Choo
Affiliate, IT Services
BioDr. Choo practices obstetrics and gynecology at Stanford Medicine Partners Pleasanton. She is bilingual in English and Korean and speaks conversational Spanish. Dr. Choo is committed to supporting women through every stage of life—from adolescence and pregnancy to menopause and beyond. She believes in building lasting relationships with her patients and providing compassionate, personalized care.
Outside of medicine, Dr. Choo enjoys traveling, watching Korean dramas, and singing karaoke with friends and family. -
Mehak Chopra
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioHer expertise lies in treating special populations such as athletes and students. She has also had training in dealing with cultural psychiatry issues. She has been trained to treat students with a variety of mental health issues – ADHD, Bipolar disorder, schizophrenia, eating disorders, insomnia, mood disorder and personality disorders.
-
Danny Hung-Chieh Chou
Associate Professor of Pediatrics (Endocrinology) and, by courtesy, of Chemical and Systems Biology
Current Research and Scholarly InterestsOur research program integrates concepts of chemical biology, protein engineering and structure biology to design new therapeutic leads and generate probes to study biological processes. A key focus of our lab is insulin, an essential hormone in our body to reduce blood glucose levels. We generate synthetic libraries of insulin analogs to select for chemical probes, and investigate natural insulin molecules (e.g. from the venom of fish-hunting cone snails!) to develop novel therapeutic candidates. We are especially interested in using chemical and enzymatic synthesis to create novel chemical entities with enhanced properties, and leverage the strong expertise of our collaborators to apply our skill sets in the fields of cancer biology, immunology and pain research. Our ultimate goal is to translate our discovery into therapeutic interventions in human diseases.
